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Abstract Cell-based regenerative medicine therapies
have been proposed for repairing the degenerated inter-
vertebral disc (a major cause of back pain). However, for
this approach to be successful, it is essential to characterise
the phenotype of its native cells to guarantee that implanted
cells differentiate and maintain the correct phenotype to
ensure appropriate cell and tissue function. While recent
studies have increased our knowledge of the human
nucleus pulposus (NP) cell phenotype, their ontogeny is
still unclear. The expression of notochordal markers by a
subpopulation of adult NP cells suggests that, contrary to
previous reports, notochord-derived cells are retained in the
adult NP, possibly coexisting with a second population of
cells originating from the annulus fibrosus or endplate. It is
not known, however, how these two cell populations
interact and their specific role(s) in disc homeostasis and
disease. In particular, notochordal cells are proposed to
display both anabolic and protective roles; therefore, they
may be the ideal cells to repair the degenerate disc. Thus,
understanding the ontogeny of the adult NP cells is para-
mount, as it will inform the medical and scientific com-
munities as to the ideal phenotype to implant into the
degenerate disc and the specific pathways involved in stem
cell differentiation towards such a phenotype.
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Introduction
Back pain is a major international health problem. It is
estimated that approximately two-thirds of the world pop-
ulation will experience low back pain at some point in their
lives [1], with its point and one-month prevalence being,
11.9 and 23.2 %, respectively [2]. With population ageing,
the global number of people suffering from this condition
will further increase. In an attempt to identify, alleviate and
treat it, medicine has developed an armamentarium of
diagnostic and therapeutic procedures; their costs, how-
ever, together with those associated with work loss,
insurance and disability benefits have led to expenditures
mounting up to £12 billion yearly in the UK [3] and $85.9
billion in the USA [4]. In the USA alone, between 1997
and 2005, the estimated number of people suffering from
back pain increased by 20.7 % which was accompanied by
a 65 % increase (adjusted for inflation) in the overall health
expenditure to treat this condition [4]. This overwhelming
investment, however, has had no significant clinical impact
as, during the same period, self-reported measurements of
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mental health, physical functioning, work, school and
social limitations among adult patients with back pain have
worsened [4]. Thus, an improvement in and development
of novel treatment strategies are paramount to tackle such a
prevalent and disabling condition.
To date, the pathogenesis of back pain is not completely
understood. It is believed to be multifactorial in origin,
with factors such as heredity, but also obesity, occupation,
smoking, alcohol consumption and diabetes all being
implicated to various degrees [5]. Research on the inter-
vertebral disc (IVD) has shown that disc degeneration is
associated in around 40 % of cases [6] and has a probable
causal relationship with back pain [7].
The intervertebral disc
The IVD is a complex structure that provides flexibility to
the vertebral column and sustains the weight applied
through the spine. It is formed by the peripheral annulus
fibrosus (AF), a ligamentous lamellar structure composed
predominantly of type I collagen fibres, which are oriented
obliquely between lamellae and inserted into the adjacent
upper and lower vertebrae [8]. The vertebrae are covered
superiorly and inferiorly by the cartilaginous endplates,
which allow for nutrient intake and waste product removal
from the largely avascular IVD. The inner part of the AF is
characterised by a transition from type I to type II collagen
and increased proteoglycan content [8], and circumferen-
tially encloses the nucleus pulposus (NP). The NP is a
highly hydrated structure, predominantly composed of the
proteoglycan aggrecan, interspersed within an irregular
mesh of type II collagen fibres.
Only 1 % of the IVD volume is occupied by its cells [9],
but they assume a vital role, as they are responsible for
extracellular matrix synthesis and turnover. Outer AF cells
are fusiform fibroblast-like, while inner AF cells are more
rounded. The cells in the human NP are large and vacuo-
lated in the newborn, but soon after birth they become
smaller, round and are typically described as chondrocyte-
like cells [10].
The pathogenesis of disc degeneration
It is the NP that is thought to be required for generation and
maintenance of the disc’s structural integrity and is the first
structure to be affected during degeneration. NP degener-
ation is characterised by a cell-driven imbalance between
matrix synthesis and degradation [11]. Type II collagen is
gradually replaced by type I collagen, which confers a
more fibrous nature to this tissue. Proteoglycan synthesis,
particularly aggrecan, also decreases. Concurrently, there is
an up-regulation of matrix degrading enzymes, namely
MMP (matrix metalloproteinases) -1, -3, -7, -9, -10
and -13 and ADAMTS (A Disintegrin And Metallopro-
teinase with Thrombospondin Motifs) -1, -4, -5, -9 and
-15 [12–14].
Overall, these matrix changes lead to reduced osmotic
pressure, reduced hydration and ultimately impaired
mechanical function. The NP eventually loses its ability to
distribute the compressive forces between the vertebral
bodies, which are non-uniformly transferred to the AF,
generating areas of increased pressure and risk of micro-
trauma. This altered force distribution and micro-trauma
results in tears and fissures along the AF and ultimately
loss of disc height [15]; in advanced stages of degeneration,
the NP herniates outwards through the AF fissures and neo-
vessels and nerves grow inwards. Importantly, nerve
ingrowth into the usually aneural IVD is implicated in the
pain associated with these conditions [7].
Degeneration of the IVD impacts not only on this tissue,
but also on the surrounding anatomical structures, such as
spinal facets, spinal cord, nerve roots, muscle and liga-
ments, which further impair IVD function leading to back
pain.
Therapies for disc degeneration
Current medical treatments for disc degeneration rely on
conservative treatments (non-steroidal anti-inflammatory
drugs, opioids and exercise therapy) [5] and, when these
fail, on surgery.
Surgical treatments such as spinal fusion and disc
replacement have shown satisfactory results in alleviating
pain. They are, however, not devoid of complications,
including accelerated degeneration of the levels adjacent to
the fusion [16] or prosthetic disc’s migration, extrusion or
failure [17]. Most importantly, these treatments aim to
alleviate patient’ symptoms, but do not target the under-
lying disease itself.
Recent progress in tissue engineering and regenerative
medicine has increased the interest in developing a bio-
logical approach to this condition, through which cells
alone or together with biomaterials would be implanted
into the NP to both repopulate and stimulate native cells to
produce a healthier extracellular matrix.
Autologous NP cell implantation would appear a good
solution to repopulate the disc and animal studies have
shown it can retard disc degeneration [18, 19], although
concerns have been raised by this approach. As the IVD is
relatively hypocellular, a single disc would not have suf-
ficient cells for expansion, which would mean harvesting
cells from more than one disc. This would be complicated
by the fact that the method currently used to harvest disc
cells (needle puncture) has been shown to induce degen-
eration in healthy discs and to accelerate it in degenerate
ones [20]. Additionally, degenerate disc cells display
1804 Eur Spine J (2014) 23:1803–1814
123
increased senescence [21, 22], increased expression of
matrix catabolic and degrading enzymes [12, 23] and
decreased synthesis of matrix components [11, 24], prop-
erties that would make them functionally inadequate for
transplantation.
Stem cells, particularly adult mesenchymal stem cells,
have been proposed as good alternative candidates and
there is a growing body of evidence confirming their
suitability [25–30]. However, for progenitor cells to be
differentiated into the correct phenotype and adequately
replace or stimulate the native NP cell population, a
complete understanding of the cell or cells populating this
tissue is paramount. Recent studies have suggested that,
contrary to what was previously thought, notochordal cells
persist in the adult human NP, possibly coexisting with
other populations of cells. This is particularly important
since in vitro and in vivo animal work have suggested that
notochordal cells may be the ideal population to repopulate
the degenerate NP. This review will highlight recent
studies focusing on the ontogeny, development and matu-
ration of the NP cells.
The cell phenotype of the intervertebral disc: lessons
from embryology
NP development within the IVD
The embryologic origins of the IVD can be traced back to
the third week of embryonic development. Early in this
week, gastrulation occurs and the inner cell mass adopts a
more complex organisation. Gastrulation is a fundamental
embryologic phase in animal development during which
cells move and rearrange themselves to shape the three
germ layers (ectoderm, mesoderm and endoderm) that will
give rise to all the tissues and organs in the developing
embryo [31]. It is characterised by four distinct movements
(epiboly, internalisation, convergence and extension),
which are regulated by mechanisms such as cell migration,
intercalation, epithelial–mesenchymal transition and cell
shape changes [32]. By the end of the third week, the
mesoderm, from which most connective tissues originate,
undergoes a subdivision into axial mesoderm (notochord),
paraxial mesoderm (somites), intermediate mesoderm and
lateral plate mesoderm. The notochord and somites will
play a fundamental role in the formation of the primitive
axial skeleton, with the notochord occupying a midline
cranio-caudal location, where it lies ventral to the neural
tube, and both having a row of somites on each side (Fig. 1,
week 3). Although being mesoderm-derived, due to a
process of mesenchymal–epithelial transition, the noto-
chord and somites display epithelioid characteristics such
as cell polarity and cell–cell contact [33]. The main
functions of the notochord at this stage are to provide
longitudinal support to the embryo, to direct the formation
of the neural tube from the ectoderm-derived neural plate
(neurulation) [34] and to induce paraxial mesoderm seg-
mentation in pairs of cranio-caudally distributed somites
(somitogenesis) [35].
During week 4, the embryo enters organogenesis, in which
the endoderm-, mesoderm- and ectoderm-derived cells dif-
ferentiate and start to acquire the distinctive characteristics of
the specific tissues and systems they will originate [36].
During this week, the notochord induces the somites to re-
adopt mesenchymal characteristics enabling their cells to
migrate: those that migrate peripherally constitute the der-
matomyotome—these cells will later form the dermis and
muscle; the ones that migrate towards and encircle the noto-
chord and neural tube constitute the sclerotome, which will
later form the spinal skeleton [33] (Fig. 1, week 4).
During the remaining weeks of embryonic development
(5th–6th week), the migrated sclerotomal cells condense
around the notochord, and the dermatomyotomal cells migrate
further away from the midline [37] (Fig. 1, weeks 5–6). As
notochordal cells contain vacuoles that retain hydrated mate-
rials [38], this generates osmotic pressures that further induce
elongation of this structure along the midline axis.
By the beginning of week 7, the sclerotomal cells have a
distinct segmented shape with highly condensed cell regions
intercalating with looser cell regions. Occupying the most
central part along the axis of the foetus is still a continuous row
of large vacuolated notochordal cells. Between the seventh
and the end of the ninth week, the sclerotomal-derived seg-
ments containing the more loosely organised cells will push
against the notochord; conversely, the more densely arranged
sclerotomal-derived segments expand (becoming even den-
ser) to accommodate the notochord that is being pushed away
from the adjacent segments (Fig. 1, weeks 7–9).
After week 10, the segments containing the more
loosely organised cells have completely pushed the noto-
chord from their centre and will become the vertebral body
(VB); the denser sclerotomal-derived cells have expanded
even further and will become the AF, which encircles the
notochord-derived NP [37, 39] (Fig. 1, week 10).
After this stage, the main spinal structures have already
acquired their characteristic shape, with morphologically
distinct chondrocytic vertebral bodies (that will ossify after
birth) and IVD, formed by the AF and the notochordal NP.
Remnants of notochordal cells within the VB are rare
entities that may give rise to a specific type of tumours—
chordomas [40].
NP cells in the maturing IVD
At birth, the cells within the NP are morphologically
similar to those that constitute the embryonic notochord.
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They are large (25–85 lm) and contain intracellular vac-
uole-like structures [41]. They usually occur in clusters,
have well-demarcated Golgi and ‘‘immature’’ mitochondria
associated with large endoplasmic reticulum [41].
Although the content of the vacuoles in the NP cells is not
known, it has been hypothesised that, like the cells in the
developing notochord, they contain unsecreted proteogly-
cans [42]. In humans, this population of large vacuolated
notochordal cells is reported to decrease during the first
decade of life and to have disappeared after that period
[10]. There are, however, reports of a small percentage of
cells expressing notochordal markers persisting until adult
life [43]. At the same time notochordal cells start to dis-
appear, a population of smaller (averaging 10 lm in
diameter), round and non-vacuolated cells begins to pop-
ulate the NP, becoming the predominant population of cells
after the first decade of life. Owing to the morphological
similarities between these cells and articular cartilage (AC)
chondrocytes, they have been termed ‘‘chondrocyte-like
cells’’ [44] and will be referred to here as small or adult NP
cells. The notochordal cell disappearance may occur as a
response to the unique microenvironment within the NP, as
notochordal cells have been shown to have little resistance
to nutrient starvation [45] and compressive loads [46]. This
change from notochordal to small NP cells occurs before or
soon after birth occurs in humans, cows, sheep, horses and
chondrodystrophic dogs; however, other animals, such as
pigs, rabbits, non-chondrodystrophic dogs, mice and rat
retain the vacuolated morphology of NP cells until much
later in life [47].
Ontogeny of the mature NP cell
The observation that the morphology of the immature cells
differs from that of mature cells has given rise to a con-
troversy regarding the origin of the cells populating the
WEEK 3
Notochord
WEEK 4 WEEKS 5 - 6






Fig. 1 Development of the spine: third week post-conception (end of)
the notochord and the neural tube elongate and occupy a central
location along the embryo axis, with a row of somites on each side.
Fourth week post-conception (end of) the notochord induces somite
cell migration: sclerotomal cells migrate towards the midline and
separate from the dermatomyotomal cells, which then migrate to the
periphery. 5th–6th week post-conception sclerotomal cells condense
around the notochord and neural tube, and dermatomyotomal cells
migrate further away to the periphery. 7th–9th week post-conception
sclerotomal cells expand in the VB anlagen region, adopting a non-
condensed pattern and pushing notochordal cells away from its
centre; in the IVD anlagen, sclerotomal cells condense to accommo-
date the notochordal cells migrating from the adjacent segments. 10th
week post-conception the notochord is restricted to the centre of the
IVD anlagen, where it will later form the NP; on its periphery, the
condensed sclerotomal cells will become the AF, and in the adjacent
segments the non-condensed sclerotomal cells will become the VB.
( November 2012. Illustration by Sam Goddard, CMFT Clinical
Photography & Medical Illustration Services, Tel: 0161 27 64671)
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mature NP. Some authors’ state that notochordal cells die
and are replaced by a new population of cells migrating
from adjacent tissues [48]. Favouring this hypothesis are
the histological observations of rabbit notochordal NP cells
being gradually replaced by chondrocytes migrating in a
centripetal manner from the endplate [49] or from the AF
[48]; chemotactic signals derived from notochordal cells
have been implicated as being the driving forces for this
migration [50].
Other authors, however, argue that the smaller adult
NP cells, despite their distinct morphology are derived
from the original population of larger notochordal cells.
Indeed, cell size differences are not uncommon in cells
with common ancestry where these may be the result of
differences in signal variations in RNA/DNA ratios,
metabolic activity and cell cycle status, having abso-
lutely no correlation with cell ontology [42]. Thus, adult
NP cells may correspond to different stages of matu-
ration of the precursor notochordal cells. This is sup-
ported by the observation that cells from chordomas,
tumours arising from embryonic notochordal remnants,
can differentiate into chondrocyte-like cells, expressing
type II collagen and aggrecan [51] and by the in vivo
sequential transformation of mouse notochordal cells
into smaller chondrocyte-like cells after IVD needle
puncture [52].
It was not until recently that this topic was more
extensively studied and clarified by fate-mapping studies in
mice and by gene expression profiling of the bovine and
human NP cells. Choi and colleagues [40] knocked the
recombinase cre gene into the sonic hedgehog (Shh) gene
in mice. Shh is a protein required for normal NP devel-
opment and highly expressed in the embryonic notochord.
By mating these mice with reporter mice, and tracking out
descendants, the authors identified exclusively noto-
chordal-derived cells within the NP along the whole
embryologic period and until maturity [40]. Additionally,
McCann and colleagues [53] performed a similar study, but
using the gene Noto, a highly conserved transcription
factor whose expression is reported to be restricted to the
node and the notochord. Noto-cre mice were mated with
reporter mice, and the descendant’s notochord fate was
tracked from embryonic period until adulthood, again
demonstrating that the NP in the fully formed mouse IVD
is derived from the notochord.
Further supporting a notochordal origin for the adult NP
cells is the identification of cytokeratins (KRT) -8, -18
and -19 or brachyury, which are known to be expressed by
the embryonic notochord [54], and are highly expressed in
the NP of the young rat [55], chondrodystrophoid dog [56],
adult bovine [57], and both the non-degenerate and
degenerate human NP [43, 58, 59]. A further analysis of
morphologically different cells separated by size from the
bovine NP (small chondrocyte-like and large vacuolated
cells) [57, 60], confirmed a significant overlapping gene
expression between these two morphologically different
cells, including that of brachyury, supporting the theory of
a common ancestry.
Cellular heterogeneity in the NP
Although the findings described in these studies support the
existence of notochord-derived cells in the adult NP, which
in some species such as humans, have undergone differ-
entiation to morphologically smaller and rounded cells,
some recent reports unveil the possibility of this notochord-
Table 1 Transcription factors and signalling molecules expressed by cells in the notochordal/immature NP






Fate-mapping studies (embryonic stages to maturity) (McCann
et al. 2011)
Transcription factor whose expression is restricted to the
organiser node and the nascent notochord during
gastrulation and axis elongation





Fate-mapping studies (embryonic stages to maturity) [40]
Signalling molecule required for patterning in the early
embryo and that is highly expressed in the embryonic
notochord
It is hypothesised to act in the induction of the floor plate and
in neural tube patterning
T (Brachyury) Rat
Microarrays (comparison between 1 and 4-month-old NP and
AF) [76]
Embryonic transcription factor regulating the transcription of
genes required for mesoderm formation and differentiation
It is localised to notochord-derived cells where it is thought
to mediate cartilage development in the developing
embryo, and also in chordomas
Bovine
qRT-PCR (comparison between 18- and 36-month-old large
notochordal and small chondrocyte-like cells) [58]
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derived population of adult NP cells coexisting with
another population NP of cells, with a different ontogeny.
Gilson and colleagues have shown that the expression of
the notochordal gene KRT-8 in the adult bovine IVD was
restricted to a subset cells, found within a morphologically
similar population of KRT-8 negative cells [61]. Weiler
and colleagues investigated the expression of KRT -8,
-18 and -19 and also galectin-3 (also expressed by the
embryonic notochord [62]) in human autopsy NP samples,
and found them to be co-expressed by a large percentage of
cells in most patients under the age of 30, but to be restricted to
subsets of clustered cells in older patients [63]. Furthermore,
and supporting the hypothesis of cells migrating from adjacent
tissues into the NP [49], Tanaka and colleagues [64], dem-
onstrated that, by inducing disc degeneration in transgenic
mice with GFP-tagged notochordal cells, a population of non-
GFP chondrocyte-like cells appeared in the NP.
The identification of tissue-specific mesenchymal stem
cells (MSCs) in tissues other than the bone marrow, adi-
pose tissue and umbilical cord, has prompted researchers to
investigate their presence within the IVD. Using a panel of
markers validated by the International Society for Cell
Therapy as bone marrow MSC markers (CD90?, CD73?,
CD105?, CD166?, CD45-, CD34-, CD14-, HLA-DR-
), Risbud and colleagues [65] identified cells within human
degenerate discs, that were capable of undergoing differ-
entiation along the chondro-, osteo- and adipogenic lin-
eages, while Blanco and colleagues [66] identified cells
capable of chondro and osteogenic differentiation. Using
BrdU labelling, Henriksson and colleagues [67] located
in vivo a population of progenitor cells in the AF border
that showed proliferation in a stem cell niche-like pattern.
More recently, Sakai and colleagues [68] identified a
subpopulation of cells within the rat and human NP
(characterised by being (Tie2 ? and GD2 ?), which were
shown to be multipotent and to undergo differentiation to
both mesenchymal and NP lineages. It remains, however,
to be elucidated whether the stem-like cells identified in
these studies derive from the embryonic notochord or from
the adjacent sclerotomal-derived tissues.
The search for the notochordal cell genetic signature
For the adult human NP to be completely characterised, it
would be important that, as with the mice fate-mapping
studies, immature notochordal cells were tracked along
different stages of development from foetal life until
maturity, independently of the morphology they assume at
those different stages. This would allow an understanding
of the different cell populations coexisting in the NP and
their ontogeny.
Additionally, there is a growing body of evidence sup-
porting a positive role for notochordal cells in the IVD.
Notochordal cells have been shown to produce more pro-
teoglycans than smaller NP cells [69] and, when in co-
culture, notochordal cells interact with small NP cells
stimulating them to produce a healthier extracellular matrix
[70, 71]. Recent findings also show that notochordal cells
can prevent Il-1-induced cell death in small NP cells [72].
Therefore, defining the notochordal cell phenotype and
tracking these cells in human discs would also allow
clarifying their role in the disc’s physiology and disease. If,
as evidence suggests, notochordal cells are the ideal cells to
repopulate/regenerate the degenerate IVD, a definition of
Table 2 Growth factors
expressed by cells the
notochordal/immature NP
Gene Species and identification method Description of the protein encoded and






1-month-old NP, 1-month-old AF and
12-month-old NP) [75]
Belongs to the BMP family of signalling
molecules that are implicated in inducing







1-month-old NP, 1-month-old AF and
12-month-old NP) [75]
Cysteine-rich secretory protein that
mediates extracellular matrix interactions
It is secreted by non-chondrodystrophic
dog’s notochordal cells and has been
shown to up-regulate proteoglycan







1-month-old NP, 1-month-old AF and
12-month-old NP) [75]
Extracellular glycosylated protein. It has a
vital role during embryonic development
and suppresses the effects of interleukin
dependent T cell growth
Its expression in IVD cells (together with
the expression of TGF-ß1, TGF-ß2 and
their receptors) were shown to decrease
with mice ageing [85]
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the notochordal phenotype would also be essential for stem
cell-based therapies.
For this to be possible, a comprehensive phenotypic
characterization of notochordal cells, and especially of
markers specific to the notochordal cells in the human IVD
would be required. To date, several attempts have been
made to identify notochordal markers, either by comparing
the gene expression of immature notochordal rat NP with
its costal cartilage [73], rat NP tissue with different degrees
of maturity [74–76], comparing immature pig NP with AF
cells [74, 77], sorted large and granular with smaller, less
granular pig NP cells [78], immature human NP with AF
cells [74] or NP from human juvenile scoliotic and adult
discs [79] (Tables 1, 2, 3, 4 list putative notochordal/
immature NP markers identified in different species and
describe their relevance to the IVD field). Proposed rat
notochordal markers identified in these studies were CD55
[73], brachyury, neuropilin (Nrp-1), CD221, BASP-1 [76],
N-Cad [73, 76], TGF-b, BMP-6 and CTGF [75]. Proposed
human young markers were CD24, CD54 and brachyury
[79]. CD90 was not expressed either in immature rat [76]
or in scoliotic juvenile NP [79] and has been proposed as a
negative notochordal cell marker. Limitations to these
studies are the use of animal models, which may not be
representative of the human intervertebral disc phenotype
and the use of scoliotic discs as a source of human
immature NP, as the scoliotic IVD, although derived from
young patients, is prematurely degenerated and subjected
Table 3 Cell surface markers expressed by cells in the notochordal/immature NP





qRT-PCR (comparison between 18- and
36-month-old large notochordal and small
chondrocyte-like cells) [58]
Calcium dependent cell–cell adhesion glycoprotein expressed
during gastrulation and that is required for the establishment
of neuronal polarity
Rat
Microarrays (comparison between 3-month-old
NP, AF and costal cartilage) [73]
CD24 Human
qPCR, immunofluorescence and flow cytometry
(comparison between adolescent and adult NP)
[79]
Cell surface protein expressed by mature granulocytes and many
B cells






qPCR, immunofluorescence and flow cytometry
(comparison between adolescent and adult NP)
[79]
Cell surface glycoprotein expressed by endothelial cells and
cells of the immune system
In cultured IVD cells, its expression is up-regulated by the





Microarrays (comparison between 3-month-old
NP, AF and costal cartilage) [73]
Membrane protein involved in the regulation of the complement
cascade, which is broadly distributed among hematopoietic
and non-hematopoietic cells
Human
Comparison between adult NP, AC and AF





qPCR, immunofluorescence and flow cytometry
(comparison between adolescent and adult NP)
[79]
Receptor for insulin-like growth factor, which has been found
overexpressed in malignant tissues where it functions as an
anti-apoptotic agent by enhancing cell survival
It is expressed by human adult NP and inner AF cells in both
non-degenerate and degenerate disc [88]. A single nucleotide
polymorphism in its gene has been associated with disc
degeneration [89]
Integrin subunits a1 and
a6
Porcine
Flow cytometry (comparison between sorted large
and more granular and smaller and less granular
NP cells)
Integrins and CD239 are expressed by NP cells and are
responsible for their adhesion to laminins [74, 77]
Integrin subunits a3, a6
and ß4)
Porcine, rat and human
immunohistochemistry and flow cytometry
(comparison between immature NP and AF
cells)
CD239
Eur Spine J (2014) 23:1803–1814 1809
123
to abnormal environmental (load) stresses which may
impact on their gene expression profiles [80, 81].
Interestingly, results from microarray studies in our
group confirm the presence of some of these proposed
immature genes both in mature bovine and adult human
NP. N-cadherin was identified as a bovine and human NP
marker and BASP-1 as a bovine and human IVD marker,
with its gene expression decreasing with degeneration [57,
58]. Unpublished data from our group also indicate CD55
as a putative NP marker (50-fold higher differential
expression in NP compared to AF or AC). This, together
with the differing expression of these genes between
immature and mature rat NP, could represent a noto-
chordal, immature NP phenotype marker common to the
three species, irrespective of cell morphology. Moreover,
since genes known to be expressed by the embryonic
notochord (KRT-8, KRT-18, KRT-19, Gal-3 and brachy-
ury) are also expressed in the adult NP, particularly by
subsets of cells, these may represent markers of notochord-
derived cells in the human adult NP.
We speculate that one or a combination of some of these
notochordal markers will be specific to notochord-derived
cells, independent of their morphology, maturation or disease
state. Its/their identification will allow investigators to track
and possibly isolate and study the function of notochord-
derived cells from discs at those different maturation and
disease states. This, in turn, will allow a more thorough
understanding, at the molecular level, of the fate and role of
notochordal or notochord-derived cells in the IVD and provide
further insight into ways to tackle disc degeneration.
Table 4 Intracellular proteins expressed by cells in the notochordal/immature NP






Microarrays (comparison between 1- and
4-month-old NP and AF) [76]
Membrane-bound protein initially described as being specific
to neuronal and spinal cord cells, where it participates in
neurite outgrowth and synaptic plasticity, but later found to
be also expressed by human endothelium, developing
mammary gland, kidney, testis, and lymphoid tissues
Bovine
qRT-PCR (comparison between 18- and
36-month-old large notochordal and small
chondrocyte-like cells) [58]
Nrp-1 (neuropilin) Rat
Microarrays (comparison between 1-4 month-old
NP and AF) [76]
Transmembrane glycoprotein involved in neuronal guidance
and angiogenesis
This ligand, together with its receptor (semaphorin) is highly
expressed in the healthy human NP, but decreases with
degeneration, having therefore been proposed to act as
barriers to neuronal ingrowth in the healthy IVD [90]
KRT 8 (cytokeratin 8) Bovine
qRT-PCR (comparison between 18- and
36-month-old large notochordal and small
chondrocyte-like cells) [58]
Cytokeratins are typically expressed by epithelial cells, but are
found in a wide range of tissues including the developing
notochord
KRT 8 is involved in maintaining cellular structural integrity
and in signal transduction and cellular differentiation
KRT 18 typically dimerises with KRT8 to form an intermediate
filament in simple single-layered epithelial cells
KRT19 is the smallest known acidic cytokeratin. It is found in
the periderm, a transient structure that functions as a
protective layer for the embryonic skin
Keratins 8 and 18 are involved in resistance against TNF-
alpha-induced apoptosis in hepatocytes [91]. Since TNF-
alpha is implicated in nerve in the ingrowth into the IVD [92],
and hence in back pain pathogenesis [7], they may act as
regulators of this ingrowth
Since intermediate filaments are usually present in cells
subjected to mechanical stress it is possible that, in the IVD,
these proteins act to withstand the hydrostatic pressures in the
NP [10]
KRT 18 (cytokeratin 18) Bovine
qRT-PCR (comparison between 18- and




foetal to mature NP). [63]
KRT 19 (cytokeratin 19) Bovine
qRT-PCR (comparison between 18- and








Differences in cell attachment, spreading and
adhesion strength between immature pig NP
and AF cells
Lamins are heterodimeric proteins involved in cell adhesion,
migration, proliferation, differentiation and survival [74, 77]
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Pending questions and potential clinical implications
Overall, current data suggest that the adult NP may contain
two different populations of cells: one that is notochord
derived, and another which is derived from cells migrating
from adjacent tissues, possibly the AF; and that in some
species, such as the human, both populations of cells have
acquired a similar chondrocyte-like morphology due to the
unique microenvironment in which they reside.
These findings have implications for understanding NP
development, maturation, and disc degeneration. The exact
function of these two populations of cells within the disc
remains to be explained. If, as suggested by Tanaka and
colleagues [64], the migration of cells occurs as a response
to a mechanical insult inducing degeneration, what is the
exact role of these migrating cells? Are they part of the
degenerative process or an attempt to repair?
Additionally, the notochordal cell ‘‘loss’’ from the NP
has been historically implicated in the degenerative pro-
cess. The reasons for this are based on observations of
human post-mortem disc samples, where the occurrence of
the histological signs of disc degeneration correlates with
the disappearance of those cells, and also in the fact that
chondrodystrophic dogs develop spinal disorders and disc
herniations, whereas non-chondrodystrophic dogs (in
which notochordal cells are retained) are resistant to these
degenerative disc diseases [41, 70, 82, 83]. This concept is
further supported by the aforementioned anabolic and
protective role these cells have shown to have in the IVD
and its cells. If notochordal cells have such a positive effect
in the IVD, is it lost upon this cell morphology change?
It will also be important to understand why this mor-
phology change is restricted to some animal species, such
as the human, but does not occur in other animals. If, as
postulated above, cell morphology does not reflect cell
ontogeny in the adult NP, as cells from different origins
can display a similar morphology, possibly the chondro-
cyte-like morphology reflects the unique physio/chemical
microenvironment in which the cells reside. In this way, it
may be that the NP niche is responsible for the differen-
tiation of both the large vacuolated notochord-derived cells
and the fibroblastic AF-derived cells to the deceivingly
homogeneous population of small round chondrocyte-like
cells in the adult NP.
Answers to these and other questions will help to
understand fundamental biological processes acting on
this complex structure from the foetal stage until maturity
and also through degeneration. Most attempts to repair or
regenerate the NP aim at repopulating this tissue with
cells capable of producing a healthier extracellular matrix
themselves or of stimulating resident cells. Improved
understanding of the ontogeny of the human adult NP
cells will inform regenerative medicine as to which
cell(s) or which microenvironmental modifications to
pursue.
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